@ljpharmD901 👏👏
Check out this publication by Dr. Lauren Andrews and Dr. Scott Benken on COVID-19. See the link here: https://t.co/f057Pyn0wf
COVID-19: #ICU delirium management during SARS-CoV-2 pandemic—pharmacological considerations @Crit_Care | #ECM https://t.co/8MBouNPTDn
COVID-19: #ICU delirium management during SARS-CoV-2 pandemic—pharmacological considerations @Crit_Care | #ECM https://t.co/uvKupavQwW
Curious what strategies the #TwitterRX group used during the #COVID19 sedative shortages... Our #PharmICU team used PO meds to offset IV needs (while keeping #delirium in mind). What about you? 🧠🧠🧠 @ETNCCRX @DRxDray @MeganARech @CMageePharmD @KLFrx @karen
Interesting conversation about delirium in Covid19: "Though it is now known that antipsychotics do not treat delirium itself" https://t.co/sNTRgMjLXi Based on publication of Kotfis et al @KatarzynaKotfis https://t.co/AstEBd0QGP
@ISICEM Covid-19 input: #COVIDー19 : ICU delirium management during SARS-CoV-2 pandemic—pharmacological considerations @jlvincen #criticalcare #intensivecare #FOAMed #FOAcc #openaccess https://t.co/EyDN0lbdsv
My first letter to the editor was published in #BMC @Crit_Care yesterday! Thankful to @KatarzynaKotfis, et al. for the original article & their response. Great opportunity to discuss RX limitations during #COVID & how they impact #delirium in the #